Article
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.
Leukemia - 1 Jul 2012
Quintana-Bustamante O, Lan-Lan Smith S, Griessinger E, Reyal Y, Vargaftig J, Lister T A, Fitzgibbon J, Bonnet D
Abstract excerpt
CCAAT/enhancer-binding protein-α (C/EBPα/CEBPA) is mutated in approximately 8% of acute myeloid leukemia (AML) in both familial and sporadic AML and, with FLT3 and NPM1, has received most attention as a predictive marker of outcome in patients with normal karyotype disease. Mutations clustering to either the N- or C-terminal (N- and C-ter) portions of the protein have different consequences on the protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
